Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - CASH FROM OPERATIONS
Cash from Operations DMAC - DiaMedica Therapeutics Inc.
-18.7 M
LAST VALUE
-23.64%
2 YEAR CAGR
-26.88%
5 YEAR CAGR
-13.03%
10 YEAR CAGR